Optimization of biomarkers-based classification scores as progression-free survival predictors: an intuitive graphical representation
نویسندگان
چکیده
منابع مشابه
Using the factors identified as independent predictors for progression-free survival, patients
Original Articles haematologica | 2010; 95(10) 1705 ©F err ata S tor ti F ou nd ati on
متن کاملCardiovascular biomarkers and carotid IMT scores as predictors of cognitive function.
OBJECTIVE Multiple cardiovascular risk factors are associated with early cognitive decline. Measures of complex information processing provide one of the earliest signs of cognitive decline and appear related to arterial plaque growth. The purpose of this study was to determine how cardiovascular risk factors and carotid intima-media thickness (IMT) scores are associated with cognitive function...
متن کامل18F-FDG PET/CT as an indicator of progression-free and overall survival in osteosarcoma.
UNLABELLED The aim of our study was to retrospectively evaluate whether maximum standardized uptake value (SUV(max)), total lesion glycolysis (TLG), or change therein using (18)F-FDG PET/CT performed before and after initial chemotherapy were indicators of patient outcome. METHODS Thirty-one consecutive patients who underwent (18)F-FDG PET/CT before and after chemotherapy, followed by tumor r...
متن کاملNoise-free representation based classification and face recognition experiments
The representation based classification has achieved promising performance in high-dimensional pattern classification problems. As we know, in real-world applications the samples are usually corrupted by noise. However, representation based classification can take only noise in the test sample into account and is not able to deal with noise in the training sample, which causes side-effect on th...
متن کاملOverview: progression-free survival as an endpoint in clinical trials with solid tumors.
Progression-free survival (PFS) is increasingly used as an important and even a primary endpoint in randomized cancer clinical trials in the evaluation of patients with solid tumors for both practical and clinical considerations. Although in its simplest form, PFS is the time from randomization to a predefined endpoint, there are many factors that can influence the exact moment of when disease ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Future Science OA
سال: 2018
ISSN: 2056-5623
DOI: 10.4155/fsoa-2018-0020